TORONTO, March 11, 2019 /CNW/ - 48North Cannabis Corp. ("48North" or the "Company") (TSXV:NRTH) is pleased to announce that its wholly-owned subsidiary Good & Green, a licensed cannabis producer under the Cannabis Act, received its Standard Processing License ("Processing License") from Health Canada on March 8, 2019.
This is 48North's second Processing License from Health Canada; the Company's first Processing License was granted for its Delshen Therapeutics facility in Kirkland Lake, On. This additional license solidifies 48North's ability to launch next-generation cannabis products for retail sale in fall 2019.
Pending Health Canada approval, 48North will be one of the first Licensed Producers in Canada to have an outdoor cannabis farm ("The Good Farm") expected to produce over 40,000 KG of dried cannabis, from over 3.7 million sq. ft. of cultivation space, at a low-cost. 48North plans on using the majority of this significant production volume for extracted, value-added products.
The Processing License at Good & Green, located 10-minutes away from The Good Farm, successfully guarantees 48North's ability to extract and process its sun-grown organic cannabis for next-generation cannabis products.
"Good & Green's Processing License further expedites 48North's ability to produce and develop next-generation cannabis products earmarked for sale in fall 2019. Coming on the heels of 48North's previously announced licensed agreements with U.S.-based brands like Mother & Clone and Avitas, the Company is now fully-licensed to bring next-generation, market-leading cannabis products to Canadian consumers in time for the next phase of legalization," said Jeannette VanderMarel, co-CEO of 48North.
48North Cannabis Corp. (TSXV: NRTH) is a vertically integrated cannabis company focused on the health and wellness market through cultivation and extraction, as well as the creation of innovative, authentic brands for next-generation cannabis products. 48North is developing formulations and manufacturing capabilities for its own proprietary products, as well as positioning itself to contract manufacture similar products for third parties. 48North operates two indoor-licensed cannabis production sites in Ontario with more than 86,000 square feet of production capacity. 48North cultivates unique genetics at its wholly owned subsidiaries, DelShen Therapeutics Corp. ("DelShen") and 2599760 Ontario Corp. dba Good & Green, both Licensed Producers under the Cannabis Act. In addition, 48North expects to operate a 100-acre organic farm providing 48North with organic, sun-grown cannabis securing a significant first-mover advantage in the production of low-cost, next-generation, extract-based cannabis products. 48North has a growing portfolio of brands that include Latitude, a women's cannabis platform (explorelatitude.com), Mother & Clone, a rapid-acting sublingual cannabis nanospray (momandclone.com) and Avitas, a single strain vaporizer cartridge (avitasgrown.com).
DISCLAIMER & READER ADVISORY
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties' current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. Forward-looking statements in this news release include statements relating to the business plan and future operations of the Company, including its application with Health Canada for a cultivation licence for its 100-acre outdoor grow property. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including the possibility that the business plan described herein will not be completed, that 48North may not derive the expected benefits from such business plans, or that applicable regulatory approvals will be obtained to carry out the activities contemplated herein. The business of the Company is subject to a number of material risks and uncertainties. Please refer to the Company's SEDAR filings for further details. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the Company being able to obtain the necessary corporate, regulatory and other third-party approvals, and licensing and other risks associated with the Cannabis Act. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward-looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
SOURCE 48North Cannabis Co.
For further information: Jeannette VanderMarel, Chief Executive Officer, (firstname.lastname@example.org); Connor Whitworth, Director of Corporate Affairs, (email@example.com), 416-788-8869